Randall W. Hungate

2.5k total citations
51 papers, 1.4k citations indexed

About

Randall W. Hungate is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Randall W. Hungate has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Randall W. Hungate's work include Chemical Synthesis and Analysis (9 papers), HIV/AIDS drug development and treatment (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Randall W. Hungate is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), HIV/AIDS drug development and treatment (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Randall W. Hungate collaborates with scholars based in United States, China and Germany. Randall W. Hungate's co-authors include Samuel J. Danishefsky, Richard Kendall, Kenneth A. Thomas, Ruth Z. Rutledge, Andrew J. Tebben, Harold G. Selnick, David M. Armistead, Francine E. Wincott, Bruce H. Lipshutz and Mark E. Fraley and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Randall W. Hungate

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randall W. Hungate United States	22	748	643	141	120	109	51	1.4k
Johannes D. Aebi Switzerland	24	606 0.8×	1.1k 1.6×	93 0.7×	121 1.0×	164 1.5×	40	1.6k
Renukadevi Patil United States	23	920 1.2×	640 1.0×	163 1.2×	82 0.7×	200 1.8×	48	1.7k
Lawrence R. McGee United States	19	742 1.0×	613 1.0×	110 0.8×	101 0.8×	124 1.1×	28	1.3k
Charles G. Caldwell United States	20	510 0.7×	428 0.7×	160 1.1×	87 0.7×	115 1.1×	32	1.0k
R. Michael Lawrence United States	21	701 0.9×	952 1.5×	136 1.0×	215 1.8×	74 0.7×	45	1.6k
Kim F. McClure United States	22	823 1.1×	1.1k 1.7×	179 1.3×	192 1.6×	76 0.7×	40	2.0k
Steven E. Hall United States	20	574 0.8×	952 1.5×	126 0.9×	69 0.6×	139 1.3×	40	1.5k
Derek R. Buckle United Kingdom	23	1.1k 1.5×	999 1.6×	135 1.0×	95 0.8×	249 2.3×	67	2.0k
Mark G. Saulnier United States	21	954 1.3×	807 1.3×	173 1.2×	97 0.8×	80 0.7×	49	1.7k
Steven R. Schow United States	17	390 0.5×	439 0.7×	146 1.0×	78 0.7×	66 0.6×	41	918

Countries citing papers authored by Randall W. Hungate

Since Specialization

Citations

This map shows the geographic impact of Randall W. Hungate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall W. Hungate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall W. Hungate more than expected).

Fields of papers citing papers by Randall W. Hungate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall W. Hungate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall W. Hungate. The network helps show where Randall W. Hungate may publish in the future.

Co-authorship network of co-authors of Randall W. Hungate

This figure shows the co-authorship network connecting the top 25 collaborators of Randall W. Hungate. A scholar is included among the top collaborators of Randall W. Hungate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall W. Hungate. Randall W. Hungate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Essa, Ning Chen, Roxanne K. Kunz, et al.. (2016). Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies. ACS Medicinal Chemistry Letters. 7(7). 719–723. 4 indexed citations

Qian, Wenyuan, Jian Jeffrey Chen, Jiawang Zhu, et al.. (2011). Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency. Bioorganic & Medicinal Chemistry Letters. 22(2). 1061–1067. 7 indexed citations

Ashton, Kate S., David J. St. Jean, Steve F. Poon, et al.. (2011). Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2. Bioorganic & Medicinal Chemistry Letters. 21(18). 5191–5196. 5 indexed citations

Kaizerman, Jacob A., Wade H. Aaron, Songzhu An, et al.. (2010). Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines. Bioorganic & Medicinal Chemistry Letters. 20(15). 4607–4610. 20 indexed citations

Zeng, Qingping, Matthew P. Bourbeau, Holger Monenschein, et al.. (2010). 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20(5). 1652–1656. 15 indexed citations

Harried, Scott S., Matthew R. Kaller, Patricia López, et al.. (2009). Stereoselective Synthesis ofanti-N-Protected 3-Amino-1,2-epoxides by Nucleophilic Addition toN-tert-Butanesulfinyl Imine of a Glyceraldehyde Synthon^†. The Journal of Organic Chemistry. 74(16). 5975–5982. 19 indexed citations

McMinn, Dustin L., Yosup Rew, Athena Sudom, et al.. (2009). Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1446–1450. 18 indexed citations

Tegley, Christopher M., Vellarkad N. Viswanadhan, Kaustav Biswas, et al.. (2008). Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation. Bioorganic & Medicinal Chemistry Letters. 18(14). 3925–3928. 39 indexed citations

Chen, Ning, Roland W. Bürli, Susana Neira, et al.. (2008). Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 18(14). 4137–4141. 6 indexed citations

10.

Frohn, Mike, Vellarkad N. Viswanadhan, Alexander J. Pickrell, et al.. (2008). Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5023–5026. 22 indexed citations

11.

Biswas, Kaustav, Wenyuan Qian, Jian Jeffrey Chen, et al.. (2008). Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain. Bioorganic & Medicinal Chemistry Letters. 18(17). 4764–4769. 16 indexed citations

12.

Kunz, Roxanne K., Dawei Zhang, Andrew S. Tasker, et al.. (2008). Discovery of amido-benzisoxazoles as potent c-Kit inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5115–5117. 10 indexed citations

13.

Frohn, Mike, Han Xu, Xiaoming Zou, et al.. (2007). New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation. Bioorganic & Medicinal Chemistry Letters. 17(23). 6633–6637. 29 indexed citations

14.

Beck, Hilary P., Todd J. Kohn, Steven M. Rubenstein, et al.. (2007). Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 18(3). 1037–1041. 36 indexed citations

15.

Bürli, Roland W., Han Xu, Xiaoming Zou, et al.. (2006). Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 16(14). 3713–3718. 103 indexed citations

16.

Xi, Ning, Yunxin Bo, Elizabeth M. Doherty, et al.. (2005). Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists. Bioorganic & Medicinal Chemistry Letters. 15(23). 5211–5217. 18 indexed citations

17.

Bilodeau, Mark T., Kathleen Coll, William R. Huckle, et al.. (2003). Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR. Bioorganic & Medicinal Chemistry Letters. 13(15). 2485–2488. 13 indexed citations

18.

Fraley, Mark E., William F. Hoffman, Robert S. Rubino, et al.. (2002). Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-a]pyrimidines: A New Class of KDR Kinase Inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(19). 2767–2770. 105 indexed citations

19.

Kendall, Richard, Ruth Z. Rutledge, Xianzhi Mao, et al.. (1999). Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues. Journal of Biological Chemistry. 274(10). 6453–6460. 99 indexed citations

20.

Lipshutz, Bruce H., Keith E. McCarthy, & Randall W. Hungate. (1984). IR and NMR spectroscopic studies on 5-(acylamino)oxazoles. Rotameric mixtures of amides at ambient temperatures. The Journal of Organic Chemistry. 49(7). 1218–1221. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact